JHMV N1347A has decreased replication in the olfactory bulbs of mice. حسب Catherine M. Kerr (21492574)

LuxR G37V has decreased DNA-binding activity. حسب Chelsea A. Simpson (9579303)

Table 3_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.xlsx حسب Aihua Guo (13267712)

"…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"

Table 1_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.docx حسب Aihua Guo (13267712)

"…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"

Table 2_Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.docx حسب Aihua Guo (13267712)

"…</p>Conclusions<p>This study clarifies NOTCH1’s role in promoting cervical cancer progression and reducing radiosensitivity, with has-miR-449a as a negative regulator, providing targets for optimizing cervical cancer radiotherapy.…"

Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx حسب Rasita Vinay (21006911)

"…It has emerged as a strategy to guide LLMs in generating the desired outputs. …"

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …"

NANOG has glycosylation sites. حسب Yin Tian (181303)

The Ishihara test for colourblindness [41] encompasses stimuli that can determine the degree and type of colourblindness a person has. حسب Marcel F. Hinss (14675457)

Feasibility of AI-powered assessment scoring: Can large language models replace human raters? حسب Michael Jaworski III (22156096)

OPG147 has no effect on TBK1 or IRF3-mediated ISRE activation and HT-DNA-induced signaling. حسب Xue-Mei Yi (18851202)

The presence of the gRNA targeting <i>OPG147</i> has no effect on transcription of viral entry and early genes. حسب Xue-Mei Yi (18851202)

Biomimetic Topological Micropattern Arrays Regulate the Heterogeneity of Cellular Fates in Lung Fibroblasts between Fibrosis and Invasion حسب Xinglong Zhu (11896815)

الموضوعات:

HAstV-8 (D471S, N512D) spike has decreased or no binding to FcRn compared to wild-type HAstV-8 spike. حسب Catalina Aguilera-Flores (21743843)

Adult demyelination has no effect on PV interneuron’s firing rate or failures in autaptic responses. حسب Sara Hijazi (21656615)

Interaction plot with 95% confidence intervals generated from the GAM regression model 1 in Table 2 examining initial ED SBP and management group interactions. حسب Randeep S. Jawa (20489181)

IGF-1 has no effect on plaque burden on irradiated mice. حسب Patricia Snarski (22305205)

IGF-1 has no effect on plaque burden on irradiated mice. حسب Patricia Snarski (22305205)